| Kathryn R Rice, SLP | |
|
47 Parkway N, Brewer, ME 04412-1234 | |
| (207) 989-9052 | |
| Not Available |
| Full Name | Kathryn R Rice |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 47 Parkway N, Brewer, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124355201 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP 1260 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn R Rice, SLP 47 Parkway N, Brewer, ME 04412-1234 Ph: (207) 989-9052 | Kathryn R Rice, SLP 47 Parkway N, Brewer, ME 04412-1234 Ph: (207) 989-9052 |
News Archive
Gone are the days when a doctor's only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called "Desktop Medicine" is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
DATATRAK International, Inc., a leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its newest DATATRAK Connect Technology Partner, Clinverse, Inc. Clinverse architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials.
Equal subsidies "surprisingly powerful," in promoting use of gold-standard medications, new study shows.
Organized by Pharma IQ, a division of IQPC, the 4th Improving Solubility conference will be held March 29-31, 2010 at The Park Hyatt in Philadelphia, PA. This forum brings together pharmaceutical researchers and scientists to uncover advances in enhancing solubility, amorphous forms, bioavailability & lipid-based formulation of drugs.
› Verified 9 days ago
Amy L Bragg, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 797 Wilson St Ste 2, Brewer, ME 04412 Phone: 207-947-8493 Fax: 207-990-4819 | |
Amy L Gallant, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 74 Parkway S, Brewer, ME 04412 Phone: 207-989-7300 Fax: 207-989-4240 | |
Brenda Russell-mann, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 797 Wilson St Ste 2, Brewer, ME 04412 Phone: 207-735-4972 | |
Jenessa Chandler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 74 Parkway S, Brewer, ME 04412 Phone: 207-989-7300 | |
Ms. Kerry H Curtis, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 74 Parkway S, Brewer, ME 04412 Phone: 207-989-7300 Fax: 207-989-4240 | |
Miss Brittany Bubar, SLP-CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 250 State St, Brewer, ME 04412 Phone: 207-947-8493 |